Life Sciences Sales Training

The buyers, the risks, and the length of the sales cycle change, but the challenge is the same: help a group of experts feel confident enough to act. For example, in instruments and consumables, a reorder may take one conversation while a capital instrument waits on demos, trials, validation, and budget approval. In diagnostics and genomics, adopting a platform or assay depends on workflow fit and validation, so the account executive or field application specialist helps buyers judge how a platform or assay compares with their current methods. In software and bioinformatics, IT, security, and regulatory reviews join the scientific review, so each reviewer’s concerns have to be addressed. In contract research and manufacturing services, business development professionals sell a relationship and a capability through long evaluations with site visits, proposals, and contract negotiation. Training solutions reflect those differences, so each role builds the skills for the conversation it actually has.

As testing moves from large hospital labs to physician offices and the home, the buyer and the case move with it. Accenture’s 2022 survey of 150 senior medtech executives cited diagnostic tests moving from large hospital labs to physician offices and homes as an example of how the shift in where care happens is changing their business. A central lab director and a hospital committee may give way to practice leaders and ambulatory administrators, who may weigh turnaround time, ease of use, and staff training at each site more heavily. Sellers who tailor the message to each role, and build the case around how the test fits each setting’s workflow, give buyers a reason to act that fits their setting.

It depends on what is holding results back. Consultative Opportunity Pursuit, a Richardson program for running deals that involve many stakeholders, fits when decisions pass through trials and validation, capital approvals, IT review, or procurement, and the challenge is helping each stakeholder reach “yes” so the group can move forward. Challenger, a methodology built on research into how buyers and sellers behave, fits when buyers already know their options and feel safe staying with what is validated, and the challenge is giving them a reason to change. Consultative Selling, which builds trust through preparation, questioning, and listening, fits teams that want every customer conversation to be consistently buyer-focused, including teams where technical specialists and account managers need a shared standard for the conversation. Richardson offers each and helps organizations define the approach that fits their sales motions, roles, and customer conversations.

Yes. In a regulated field, sales professionals can make only the claims their company’s approvals and data support, so insight does not mean new claims. It means helping a buyer see how approved evidence applies to their own workflow, and what it costs to wait. Challenger, a methodology built on research into how buyers and sellers behave, builds commercial insight, a perspective that reframes how a buyer sees a problem, through a process that brings sales, marketing, and product expertise together. In life sciences, that process can include scientific, legal, and compliance reviewers so every insight stays within approved evidence. Accelerate Prism, Richardson’s AI-orchestrated system for turning training into lasting behavior change, includes AI Roleplay, which lets sales professionals rehearse these conversations with a realistic AI buyer before the stakes are real, so teams build the skill inside those boundaries. Sales training does not replace technical, quality, or regulatory expertise. It helps commercial teams use their approved evidence and their experts more effectively.

Agreeing with the value is not the same as feeling confident enough to act. Richardson calls that gap the Confidence Chasm. Challenger research published in The JOLT Effect, by Matthew Dixon and Ted McKenna, found that between 40% and 60% of lost deals end in no decision. That finding spans industries, not only life sciences, but the mechanics are familiar here: results to validate again, systems to connect, and approvals to gather from several functions. A group like this leans toward consensus, and consensus often leans toward the status quo, so the deal ends in no decision rather than a no. More specifications rarely close the gap. A reason to change that the buyer trusts, a clear path through validation and integration, and a case made to each stakeholder in terms of what that person needs can.

They add people and gates to a decision the scientist may have already made. The larger the purchase, the more people and the wider the range of priorities in the buying group, according to a ResearchGate survey of life scientists. Across industries, Forrester’s 2024 research found an average of 13 people involved in a business buying decision, with 89% of purchases involving two or more departments. In life sciences, those people often include scientists or principal investigators, lab managers, quality and regulatory reviewers, IT or informatics, and procurement. Selling to the group does not mean giving everyone the same presentation. It means making a case that speaks to each person’s concerns, so that when each person sees the value in their own terms, the group can agree to move forward. Account managers and technical specialists who raise validation and integration questions early, map the group, and find the people who will drive action when they are not in the room keep deals moving. When procurement compares suppliers and pushes on price, Richardson offers Consultative Negotiations for those conversations.

Field application scientists and technical sales specialists are often the people buyers trust most during a demo, trial, or validation. Their role is commonly described as a scientific consultant before and after the sale who partners with the commercial team. Training gives account managers and technical specialists a shared way to prepare for, run, and follow up on customer conversations, so technical credibility turns into progress in the decision. For technical specialists, it builds the ability to connect results to the business case others need. For account managers, it builds the ability to bring the specialist in at the right moment. Programs can be customized for each role.

The sale is a relationship built on capability and trust, and the evaluation is long. Business development professionals in contract research and manufacturing typically manage the full lifecycle, from identifying prospects and qualifying opportunities to proposals, contract negotiation, and long-term account growth, while engaging scientific, technical, procurement, and executive stakeholders. That puts the emphasis on understanding each program’s goals and risks, keeping momentum across a long pursuit, and negotiating without conceding value. Richardson offers Consultative Prospecting for starting conversations, Prosperous Account Strategy for growing key accounts, and Consultative Negotiations for contract talks, and training can be customized for these conversations.

Start with a baseline, then connect two kinds of data over time. Behavior data shows whether sales professionals are applying what they learned: practice results, coaching observations, and whether they are uncovering the buyer’s workflow, tailoring the case to each stakeholder, and making specific requests. Outcome data from the CRM shows what happened: win rate, no-decision losses, opportunity progression, deal size, and cycle time. Behavior data by itself shows activity, and CRM data by itself shows results with no explanation. Together they show whether specific behaviors are driving results, where gaps in skill execution remain, and what managers should coach next. Satisfaction scores and self-reported impact show how participants felt, but they do not show behavior change on their own. Accelerate Prism, Richardson’s AI-orchestrated system for turning training into lasting behavior change, includes a measurement capability called Signal, which uses data and visibility to show progress and inform next steps. Prism can connect with systems an organization already uses, including CRM, so leaders can read behavior and outcomes side by side.

Richardson uses AI orchestration to support methodology execution, individual skill development, and coaching, not to replace them, and organizations adopt only the capabilities that fit their privacy, security, and compliance requirements. In Accelerate Prism, Richardson’s AI-orchestrated system for turning training into lasting behavior change, AI supports and orchestrates the learning at the individual contributor level. It uses signals about each sales professional’s capability, learning, practice, and behavior to decide what they need next, then delivers targeted learning, reinforcement, AI-enabled nudges, and AI Roleplay, with feedback tied to the training methodology. Practice results also show managers where to coach. AI guides what sales professionals and managers do next, while the methodology, the coaching, and the quality of the training define the path to behavior change and revenue attainment.